Abveris, Inc.

Industry

  • Biotechnology
    • Drug Discovery Technologies
    • Large Molecule
      • Antibodies
    • Gene Therapy, Cell Therapy
  • In Vitro Diagnostics
  • Contract Research Organization-CRO
  • Pharmaceuticals

Other Names/Subsidiaries

  • AbX Biologics Inc.
See more in Biomedtracker

Latest on Abveris, Inc.

Scrip

Deal Watch: Lilly Teams With Regor On Metabolic Disorders

 
• By Joseph Haas and Dexter Jie Yan

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Doubles Down On Metabolic Disorde

Scrip

Deal Watch: Sanofi To Tap Owkin’s AI, Machine Learning In Oncology

 
• By Joseph Haas and Jung Won Shin

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Sanofi Hopes Owkin Can Aid Oncology Dis

Scrip

Deal Watch: Lilly Teams Up With Lycia In Protein Degradation

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Lilly Pays $35m Up Front To Access Lyci